OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
47
Results
Show all
Save search
Copy query
Show results for
Unknown
(47)
Publication Date
Release Date
2021
(11)
2018
(7)
2022
(5)
2015
(5)
2020
(4)
2025
(3)
2023
(3)
2019
(3)
2024
(2)
2017
(2)
2016
(1)
2011
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial.
Not available
S-EPMC10667090
|
biostudies-literature
Cite
Real-World Use of Talimogene Laherparepvec in German Patients with Stage IIIB to IVM1a Melanoma: A Retrospective Chart Review and Physician Survey.
Not available
S-EPMC6318239
|
biostudies-literature
Cite
A Retrospective Chart Review Study of Real-World Use of Talimogene Laherparepvec in Unresectable Stage IIIB-IVM1a Melanoma in Four European Countries.
Not available
S-EPMC7889564
|
biostudies-literature
Cite
The Role of Treatment Sequencing with Immune-Checkpoint Inhibitors and BRAF/MEK Inhibitors for Response and Survival of Patients with BRAFV600-Mutant Metastatic Melanoma-A Retrospective, Real-World Cohort Study.
Not available
S-EPMC9101790
|
biostudies-literature
Cite
Sonidegib improved quality of life in patients with advanced basal cell carcinoma: Results from the phase 2 Basal cell carcinoma outcomes with LDE225 treatment trial through 73 weeks.
Not available
S-EPMC9678756
|
biostudies-literature
Cite
Assessment of various efficacy outcomes using ERIVANCE-like criteria in patients with locally advanced basal cell carcinoma receiving sonidegib: results from a preplanned sensitivity analysis.
Not available
S-EPMC8603490
|
biostudies-literature
Cite
Anticoagulation with Factor Xa Inhibitors Is Associated with Improved Overall Response and Progression-Free Survival in Patients with Metastatic Malignant Melanoma Receiving Immune Checkpoint Inhibitors-A Retrospective, Real-World Cohort Study.
Not available
S-EPMC8534137
|
biostudies-literature
Cite
Long-term survival of patients after ipilimumab and hypofractionated brain radiotherapy for brain metastases of malignant melanoma: sequence matters.
Not available
S-EPMC6267133
|
biostudies-literature
Cite
Role of Hypoxia and the Adenosine System in Immune Evasion and Prognosis of Patients with Brain Metastases of Melanoma: A Multiplex Whole Slide Immunofluorescence Study.
Not available
S-EPMC7763902
|
biostudies-literature
Cite
The Status of Adjuvant and Neoadjuvant Melanoma Therapy, New Developments and Upcoming Challenges.
Not available
S-EPMC8484171
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets